These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21324216)

  • 1. Cost-effectiveness of targeted screening for hepatitis C in The Netherlands.
    Helsper CW; Borkent-Raven BA; de Wit NJ; van Essen GA; Bonten MJ; Hoepelman AI; Janssen MP; de Wit GA
    Epidemiol Infect; 2012 Jan; 140(1):58-69. PubMed ID: 21324216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign.
    Helsper CW; van Essen GA; Bonten MJ; de Wit NJ
    Fam Pract; 2010 Jun; 27(3):328-32. PubMed ID: 20223833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.
    Helsper CW; Janssen MP; van Essen GA; Croes EA; van der Veen C; de Wit AG; de Wit NJ
    Int J Drug Policy; 2017 Sep; 47():117-125. PubMed ID: 28826994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organized hepatitis C screening. Results and cost of a one-year campaign in a pilot area].
    Monnet E; Mercet P; Woronoff-Lemsi MC; Bresson-Hadni S; Pruniaux J; Cottray P; Bouiller C; Allemand H; Miguet JP
    Gastroenterol Clin Biol; 2000 May; 24(5):541-6. PubMed ID: 10891743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
    van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
    Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors related to screening of hepatitis C virus in general medicine].
    Rotily M; Loubière S; Prudhomme J; Portal I; Tran A; Hofliger P; Valla D; Moatti JP
    Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the cost-effectiveness of cancer screening promotion.
    Andersen MR; Urban N; Ramsey S; Briss PA
    Cancer; 2004 Sep; 101(5 Suppl):1229-38. PubMed ID: 15316909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical and economic evaluation of donated blood screening for hepatitis C and non-A, non-B, non-C hepatitis].
    Vergnon P; Colin C; Jullien AM; Bory E; Excoffier S; Matillon Y; Trepo C
    Rev Epidemiol Sante Publique; 1996 Jan; 44(1):66-79. PubMed ID: 8851944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.
    Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD
    Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
    Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
    Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection.
    Chen MY; Karvelas M; Sundararajan V; Hocking JS; Fairley CK
    Int J STD AIDS; 2007 Apr; 18(4):239-43. PubMed ID: 17509173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW; Woo G; Jenny Heathcote E; Krahn M
    Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate causal attribution and cost-effectiveness of a national mass media campaign in the Philippines.
    Kincaid DL; Do MP
    J Health Commun; 2006; 11 Suppl 2():69-90. PubMed ID: 17148100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.